Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.0215873015873016 0 0.0238095238095238 0.111428571428571
Stock impact report

Relmada prices $100M equity offering [Seeking Alpha]

Relmada Therapeutics, Inc. (RLMD) 
NASDAQ:AMEX Investor Relations: ir.relmada.com
Company Research Source: Seeking Alpha
Relmada prices $100M equity offering Relmada Therapeutics (NASDAQ: RLMD priced Underwriters' over-allotment is an additional 500,000 shares. The closing date is December 6. Net proceeds will be used to fund R&D activities related to REL-1017 (d-methadone), as well as for working capital and general corporate purposes. Show less Read more
Impact Snapshot
Event Time:
RLMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for RLMD alerts
Opt-in for
RLMD alerts

from News Quantified
Opt-in for
RLMD alerts

from News Quantified